Updated information on COVID-19 and Flu: Restricted visitation is now in effect
Category
Cancer
Sub Category
Gastrointestinal
Study Name
NRG-GI002: *TEMPORARILY CLOSED* A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer
Principal Investigator
Gordan Srkalovic MD, PhD
Study Information
https://www.clinicaltrials.gov/ct2/show/NCT02921256?term=NRG-GI002&rank=1
Contact for Questions
Nurse - Tracy 517-364-2835

Site view: at a glance